User profiles for N. K. Yellapu
Dr Nanda kumar YellapuDepartment of Biostatistics and Data Science, University of Kansas Medical Center Verified email at kumc.edu Cited by 722 |
[HTML][HTML] Obesity-induced inflammation exacerbates clonal hematopoiesis
…, TR Pandhiri, UP Dave, NK Yellapu… - The Journal of …, 2023 - Am Soc Clin Investig
Characterized by the accumulation of somatic mutations in blood cell lineages, clonal
hematopoiesis of indeterminate potential (CHIP) is frequent in aging and involves the expansion of …
hematopoiesis of indeterminate potential (CHIP) is frequent in aging and involves the expansion of …
[HTML][HTML] Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer
Background Triple-negative breast cancer (TNBC) constitutes 10–20% of breast cancers
and is challenging to treat due to a lack of effective targeted therapies. Previous studies in …
and is challenging to treat due to a lack of effective targeted therapies. Previous studies in …
Purification, characterization and molecular docking study of angiotensin-I converting enzyme (ACE) inhibitory peptide from shortfin scad (Decapterus macrosoma) …
NH Ishak, MI Shaik, NK Yellapu, NK Howell… - Journal of food science …, 2021 - Springer
Hypertension is a threatening chronic disease, which become a global killer among the
adult population. The mortality rate increasing day by day even several Angiotensin I-converting …
adult population. The mortality rate increasing day by day even several Angiotensin I-converting …
Randomized phase IIB trial of the lignan secoisolariciresinol diglucoside in premenopausal women at increased risk for development of breast cancer
We conducted a multiinstitutional, placebo-controlled phase IIB trial of the lignan secoisolariciresinol
diglucoside (SDG) found in flaxseed. Benign breast tissue was acquired by random …
diglucoside (SDG) found in flaxseed. Benign breast tissue was acquired by random …
MORC2 and MAX contributes to the expression of glycolytic enzymes, breast cancer cell proliferation and migration
RK Guddeti, H Pacharla, NK Yellapu, P Karyala… - Medical Oncology, 2023 - Springer
Cancer cell proliferation is a high energy demanding process, where the cancer cells acquire
energy by high rates of glycolysis, and this phenomenon is known as the “Warburg effect”. …
energy by high rates of glycolysis, and this phenomenon is known as the “Warburg effect”. …
Bioenergetic and inflammatory systemic phenotypes in Alzheimer's disease APOE ε4‐carriers
…, H Anderson, E Schwartz, D Pei, NK Yellapu… - Aging cell, 2021 - Wiley Online Library
We examined the impact of an APOE ε4 genotype on Alzheimer's disease (AD) subject
platelet and lymphocyte metabolism. Mean platelet mitochondrial cytochrome oxidase Vmax …
platelet and lymphocyte metabolism. Mean platelet mitochondrial cytochrome oxidase Vmax …
Microrchidia 2/histone deacetylase 1 complex regulates E-cadherin gene expression and function
L Thomas, N Chutani, AS Nair, NK Yellapu… - Biochemical …, 2023 - portlandpress.com
Although Microrchidia 2 (MORC2) is widely overexpressed in human malignancies and
linked to cancer cell proliferation, metabolism, and metastasis, the mechanism of action of …
linked to cancer cell proliferation, metabolism, and metastasis, the mechanism of action of …
[HTML][HTML] Molecular designing and in silico evaluation of darunavir derivatives as anticancer agents
M kumar Mahto, NK Yellapu, RB Kilaru… - …, 2014 - ncbi.nlm.nih.gov
Darunavir is a synthetic nonpeptidic protease inhibitor which has been tested for anticancer
properties. To deduce and enhance the anticancer activity of the Darunavir, we have …
properties. To deduce and enhance the anticancer activity of the Darunavir, we have …
[HTML][HTML] Modeling, molecular docking, probing catalytic binding mode of acetyl-CoA malate synthase G in Brucella melitensis 16M
PJ Adi, NK Yellapu, B Matcha - Biochemistry and Biophysics Reports, 2016 - Elsevier
There are enormous evidences and previous reports standpoint that the enzyme of glyoxylate
pathway malate synthase G (MSG) is a potential virulence factor in several pathogenic …
pathway malate synthase G (MSG) is a potential virulence factor in several pathogenic …
Synthesis of N-(3-picolyl)-based 1,3,2λ5-benzoxazaphosphinamides as potential 11β-HSD1 enzyme inhibitors
…, SS Chereddy, VR Pasupuleti, NK Yellapu… - Medicinal Chemistry …, 2015 - Springer
Inhibition of 11β-HSD1 enzymatic action is perceived as a potential target for the treatment
of metabolic syndromes like cardiovascular diseases, obesity, and diabetes. In an attempt to …
of metabolic syndromes like cardiovascular diseases, obesity, and diabetes. In an attempt to …